CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,355,000 | -14.5% | 119,147 | -18.1% | 0.11% | -23.4% |
| Q1 2019 | $13,273,000 | -1.4% | 145,462 | -18.0% | 0.14% | -19.0% |
| Q4 2018 | $13,464,000 | -39.4% | 177,365 | -36.2% | 0.18% | -29.5% |
| Q3 2018 | $22,233,000 | -21.7% | 277,915 | -2.8% | 0.25% | -25.7% |
| Q2 2018 | $28,394,000 | +20.0% | 285,859 | -2.2% | 0.34% | +11.8% |
| Q1 2018 | $23,669,000 | +31.6% | 292,216 | +28.0% | 0.31% | +28.0% |
| Q4 2017 | $17,989,000 | +41.8% | 228,373 | +66.1% | 0.24% | +39.0% |
| Q3 2017 | $12,685,000 | – | 137,482 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |